Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

Card image cap

Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal dementia (FTD) in mice – and may even offer the potential to reverse some of the effects of the fatal diseases.

Related Keywords

Australia , Bruce Willis , Lars Ittner , Neuroscientists At Macquarie University , Macquarie University , Professor Lars Ittner , Professor Ittner , Celosia Therapeutics , Dementia , Frontotemporal Dementia , Enetic , Lzheimer 39s Disease , Rain , Edicine , Eurons , Rotein , Esearch , Tdp 43 , Herapeutics ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.